A couple of joint ventures were throw in the deal mix for March and April, including one that would give a French company entry into the lucrative China market.
Theraclion SAS, based in Malakoff, France, has set up a JV with one of its shareholders, Chinese healthcare company Inner Mongolia Furui Medical Science Co. Ltd., in the city of Shenzhen. Theraclion China Co, Ltd. will sell the French company's Echopulse system, designed as a noninvasive alternative to surgery by excising benign thyroid nodules and removing breast fibroadenoma using high-intensity focused ultrasound (HIFU)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?